Gregor MacRae
Corporate Officer/Principal bei Appledore Wealth Management LLP
Profil
Gregor MacRae is a Senior Partner at Appledore Wealth Management LLP.
He was a Non-Executive Director at OKYO Pharma Ltd.
from 2019 to 2020 and at Tiziana Life Sciences Ltd.
(United Kingdom) in 2020.
He is a graduate of the University of Birmingham.
Aktive Positionen von Gregor MacRae
Unternehmen | Position | Beginn |
---|---|---|
Appledore Wealth Management LLP | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Gregor MacRae
Unternehmen | Position | Ende |
---|---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 18.06.2020 |
OKYO PHARMA LIMITED | Direktor/Vorstandsmitglied | 10.06.2020 |
Ausbildung von Gregor MacRae
University of Birmingham | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OKYO PHARMA LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Appledore Wealth Management LLP |